Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGames Workshop Regulatory News (GAW)

Share Price Information for Games Workshop (GAW)

Share Price is delayed by 15 minutes
Get Live Data
18,980.00    -120.00 (-0.63%)
Bid:
18,980.00
Ask:
19,010.00
Spread: 30.00 (0.158%)
Market Cap: £6.27b
GAW Live PriceLast checked at - London Stock Exchange

Intraday Games Workshop Share Chart

Trading Statement

25 Jul 2017 07:00

RNS Number : 9485L
Games Workshop Group PLC
25 July 2017
 

Games Workshop Group PLC

 

TRADING STATEMENT

 

For the period from 29 May 2017 to 23 July 2017

 

 

 

For immediate release 25 July 2017

 

Following on from the Group's good performance in 2016/17, trading has continued strongly into 2017/18 such that sales and profits for 2017/18 to date are well above the same period in the prior year. Profits for 2017/18 are therefore likely to be above market expectations.

 

However, the Board remains aware that there is some uncertainty in the trading periods ahead for the rest of the 2017/18 financial year. A further update will be given as appropriate.

 

 

 

 

 

 

 

 

 

 

For further information, please contact:

 

Games Workshop Group PLC

 

0115 900 4003

Kevin Rountree, CEO

 

 

Rachel Tongue, Group Finance Director

 

 

 

 

 

Investor relations website

http://investor.games-workshop.com

General website

www.games-workshop.com

 

 

 

 

 

 

 

 

 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTZMGZNNDMGNZM
Date   Source Headline
9th Jan 20247:02 amRNSDividend
9th Jan 20247:00 amRNSHalf-yearly Report
2nd Jan 202412:16 pmRNSTotal Voting Rights
18th Dec 20239:00 amRNSDisclosure of New Directorship
18th Dec 20237:00 amRNSAgreement to develop films and television series
7th Dec 20237:00 amRNSHalf Year Trading Update
1st Dec 20232:08 pmRNSTotal Voting Rights
7th Nov 20233:09 pmRNSDirector Shareholding
1st Nov 20237:00 amRNSTotal Voting Rights
2nd Oct 20237:00 amRNSTotal Voting Rights
20th Sep 20232:32 pmRNS2023 AGM voting results
15th Sep 20237:00 amRNSTrading Update and Dividend
14th Sep 20237:00 amRNSHolding(s) in Company
13th Sep 20237:00 amRNSDirector Shareholding
1st Sep 20239:53 amRNSBlock listing Interim Review
1st Sep 20239:01 amRNSTotal Voting Rights
21st Aug 20232:37 pmRNSHolding(s) in Company
21st Aug 20238:51 amRNSHolding(s) in Company
4th Aug 20233:24 pmRNSHolding(s) in Company
3rd Aug 20237:00 amRNSDirector Shareholding
1st Aug 20239:51 amRNSTotal Voting Rights
25th Jul 202312:42 pmRNSNotice of AGM and Related Party Transactions
25th Jul 20237:01 amRNSDividend
25th Jul 20237:00 amRNSAnnual Report
3rd Jul 20237:00 amRNSTotal Voting Rights
14th Jun 20237:00 amRNSYear End Trading Update
1st Jun 20237:00 amRNSTotal Voting Rights
22nd May 20231:02 pmRNSDirector Shareholding
18th May 20231:06 pmRNSDirectorate Change
17th May 20239:28 amRNSHolding(s) in Company
2nd May 20237:00 amRNSTotal Voting Rights
12th Apr 20237:00 amRNSDirectorate Changes
3rd Apr 20238:18 amRNSTotal Voting Rights
30th Mar 20233:11 pmRNSHolding(s) in Company
24th Mar 20232:40 pmRNSDirector Shareholding
24th Mar 202311:31 amRNSDividend Update
24th Mar 20237:00 amRNSTrading Update and Dividend
1st Mar 202312:24 pmRNSBlock listing Interim Review
1st Mar 202310:01 amRNSTotal Voting Rights
27th Feb 202311:50 amRNSDirector Shareholding
17th Feb 20237:00 amRNSDirector/PDMR Shareholding
1st Feb 202312:43 pmRNSTotal Voting Rights
10th Jan 20237:01 amRNSDividend
10th Jan 20237:00 amRNSHalf-year Report
3rd Jan 202310:06 amRNSTotal Voting Rights
16th Dec 20227:00 amRNSAgreement in principle to develop film and TV
7th Dec 20227:01 amRNSAppointment of Chair
7th Dec 20227:00 amRNSHalf Year Trading Update
5th Dec 20227:00 amRNSTotal Voting Rights
2nd Nov 20222:31 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.